iifl-logo

Norris Medicines Ltd Board Meeting

Add as a Preferred Source on Google
14.96
(5.43%)
May 27, 2026|03:14:00 PM

Norris Medicines CORPORATE ACTIONS

27/05/2025calendar-icon
27/05/2026calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting14 Feb 202611 Feb 2026
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 inter alia to consider and approve As per attachment. As per attachment (As Per BSE Announcement Dated on:14.02.2026)
Board Meeting14 Nov 20258 Nov 2025
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to consider and approve As per attachment As per attachment. (As Per BSE Announcement Dated on 14.11.2025)
Board Meeting1 Sep 20251 Sep 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On Monday, 01St September, 2025 Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Board Meeting14 Aug 202511 Aug 2025
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve As per attachment. As per attachment (As Per BSE Announcement Dated on: 14/08/2025)
Board Meeting28 May 202523 May 2025
Norris Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve As per attachment. As per attachment. (As Per BSE Announcement Dated on :28.05.2025)

Norris Medicines: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.